MedPath

In-vivo Bioequivalence Test of Flecainide acetate tablets with brand drug (TAMBOCOR® 100 mg FC Tab, MEDA Pharmaceuticals LLC, USA)

Not Applicable
Recruiting
Conditions
Bio equivalence test.
Registration Number
IRCT20200105046010N48
Lead Sponsor
Arena Hayat Danesh Pharmaceutical Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

General health
Body mass index between18-28
Informed consent
Being at the age of 18-55 years old

Exclusion Criteria

Smoking
A history of cardiovascular disease
A history of liver & kidney disease
Pregnancy
Alcohol & Drug addiction
Hypersensitivity to the drug

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.